Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This trial uses semi-structured interviews and focus groups to determine facilitators and barriers of receiving timely cancer treatment among multiple cancers, across multiple insurance types, throughout Texas
Full description
Primary Objectives:
Aim 1: To comprehensively assess barriers to and facilitators of receiving timely cancer treatment, via in-depth telephone interviews among a purposive sample of Texas patients with Stage I-IV breast, colorectal, lung, and prostate cancer and diverse backgrounds.
Aim 2: To generate consensus on barriers and facilitators, as well as their relative importance, via focus groups, among carefully selected Texas patients with Stage I-IV breast, colorectal, lung and prostate cancer and diverse backgrounds,
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Aims 1 and 2
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Exclusion criteria
Aims 1 and 2
An individual who meets any of the following criteria will be excluded from participation in this study:
Primary purpose
Allocation
Interventional model
Masking
120 participants in 2 patient groups
Loading...
Central trial contact
John Lin, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal